All Type of News
‘PharmaTech Business Center’ consisting of 77 people from 40 companies to be established
At the Geranium Hall of Hotel Samjung Seoul at 13:20 on the 28th of February, the Korea Drug Research Association(President Dong-Yeon Kim, hereinafter referring to KDRA) will held the ‘Inauguration Ceremony of the 17t...
Yuhan, Chong Kun Dang and Hanmi’s outpatient prescriptions increased by over 10%
Last January, outpatient prescriptions were analyzed to record KRW 959.8 billion increased by 5.9% compared to the last year. Among the top pharmaceutical companies, moreover, Yuhan Corporation, Chong Kun Dang and Han...
Kolmar Korea distributes Twynsta-referencing first generic ‘Telopine Tab’ to 20 pharmas
Kolmar Korea, a global CMO(contract manufacturing organization), announced on the 22nd that it has succeeded in developing ‘Telopine Tab,’ the first generic referencing the top sales drug in the antihypertensive marke...
Pharmas share COD(collect on delivery) expenses with distribution companies
While the pharmaceutical distribution industry is experiencing difficulties, such as unacceptance and delay over returns of disused and stored drugs, pharmaceutical companies have caused an issue again as shifting exp...
HIRA holds the open debate with pharmaceutical industry
In order to communicate with the pharmaceutical industry, the Health Insurance Review & Assessment Service(President Myong-Sei Sohn, hereinafter referring to ‘HIRA’) held a debate with people working in the pharmaceut...
Big5 Pharmas grown externally, but decreased in profitability
As Yuhan Corporation made KRW 1.3308 trillion sales, Korean pharmaceutical companies have externally grown, but it was criticized they lost profitability.
According to the Yakup Shinmoon’s(www.yakup.com) analysis re...
MFDS rejects National Assembly’s request to consider excluding drugs from Serial Number Reporting System
The Ministry of Food and Drug Safety(MFDS) rejected to accept the National Assembly’s request to consider the plan to apply the serial number reporting system only on narcotics and antipsychotic injections.
The MFD...
KoreaBio’s opposition to KPMA’s use of word ‘Bio’ in their name
On the 22nd, the Korea Biotechnology Industry Organization(President Jeong-Sun Seo, hereinafter referring to KoreaBio) officially announced an opinion of opposing the Korea Pharmaceutical Manufacturers Association(KPM...
8 Korean pharmas incremented in bidding grade with PIC/S membership
The Ministry of Food and Drug Safety(MFDS) announced on the 22nd the Vietnamese government has incrementally adjusted the public bidding grade for Korean pharmaceutical companies’ generic products, which will be suppl...
Kyeong-Ho Lee, “I’ll always cheer for improvement of the Korean pharmaceutical industry ”
Korea Pharmaceutical Manufacturers Association(KPMA) Chairman Kyeong-Ho Lee, who will leave the association at the end of February after the 6 years of service, delivered a message to the member companies, “I’ll alway...
